We previously hypothesized that the endothelial cell dysfunction observed in women with preeclampsia might be caused by an imbalance between circulating very low density lipoproteins and a cytoprotective pI 5.6 isoform of albumin, referred to as toxicity preventing albumin (TxPA). An accurate simplified method was developed to quantify TxPA in small volumes of pregnancy plasma by gel electrofocusing. This assay revealed that circulating TxPA concentrations in women with severe preeclampsia were significantly reduced compared to those in normal pregnant women and women with benign transient hypertension of pregnancy. Nonesterified fatty acids (NEFA) and triglycerides were elevated in plasma from women with severe preeclampsia compared to those in plasma from the two control groups. The inverse correlation between TxPA and NEFA values led us to analyze the NEFA bound to plasma albumin. Gas chromatography and mass spectrometry demonstrated no qualitative differences in the specific fatty acids bound to plasma albumin in severe preeclamptic and normal pregnant women. However, the quantity of NEFA bound to albumin was greater in preeclampsia plasma (2.5 mol NEFA/mol albumin) compared to that in normal pregnancy plasma (0.8 mol NEFA/mol albumin), accounting for the acidic pI shift observed in albumin from the former patients. Functional assays demonstrated that human very low density lipoprotein particles were toxic to human umbilical vein endothelial cells in vitro, but this toxicity was prevented by the addition of TxPA albumin to the culture medium. (J Clin Endocrinol Metab 82: 3786 -3792, 1997) P REECLAMPSIA is a common, pregnancy-specific syndrome of unknown etiology, defined by the clinical findings of elevated blood pressure, proteinuria, and pronounced edema. Despite its clinical recognition since antiquity, the pathophysiology of preeclampsia remains poorly understood. Over the past 8 yr, investigations into the pathogenesis of preeclampsia have revealed the importance of endothelial cell injury in this disease (1). More recently, the role of abnormal lipid metabolism has been demonstrated (2, 3). Endresen et al. (4) were the first to report that a high molar ratio of free fatty acids to albumin correlated best with endothelial cell dysfunction in vitro. We hypothesized that the endothelial cell dysfunction observed in preeclampsia might be caused by an imbalance between circulating very low density lipoproteins (VLDL) and a cytoprotective isoform of plasma albumin [toxicity preventing albumin (TxPA)] (5). We previously demonstrated that plasma TxPA concentrations were decreased in women with mild preeclampsia compared to those in matched normal pregnant controls (6). In the current study we developed and verified a new method for the quantification of TxPA and extended our investigation to include pregnant women with severe preeclampsia and those with transient hypertension of pregnancy. We measured the circulating concentrations of nonesterified fatty acids (NEFA) in these patients and identified, by gas chromatography/mass spectrometry (GC/MS), the fatty acids bound to plasma albumin in preeclamptic and normal pregnancies. Our findings verified that the acidic shift in the isoelectric point of plasma albumin in preeclamptic women is due to increased NEFA binding in these subjects. The functional effects of NEFA binding to plasma albumin were tested using human umbilical vein endothelial (HUVE) cell cultures. Endothelial cell toxicity induced by VLDL particles was prevented by albumin devoid of NEFA (TxPA), but not by NEFA-bound albumin.
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(UCSF). Twelve nulliparous women with severe preeclampsia [American College of Obstetricians and Gynecologists' criteria (7)] were identified. These women were matched for maternal age (Ϯ3 yr), nulliparity, race, and body mass index (BMI) to 12 pregnant women with transient hypertension of pregnancy and to 12 normal pregnant controls. Because of the known association of NEFA concentrations with insulin resistance, women with abnormal glucose tolerance screening tests were excluded from the study. Written informed consent was provided by all participating patients under a protocol approved by the UCSF committee on human research.
The subjects were assigned to each of the three study groups by previously established strict criteria reported by Chesley (8) as recommended by the NIH consensus conference for investigations of pregnancy hypertension (9) . Preeclamptic women were nulliparous, with pregnancy-onset hypertension, proteinuria, hyperuricemia, and reversal of hypertension and proteinuria within 12 weeks after delivery. Pregnancy-onset hypertension was defined as an increase of 30 mm Hg systolic or 15 mm Hg diastolic compared to values obtained before 20 weeks' gestation or an absolute blood pressure of 140/90 mm Hg or higher. Proteinuria was designated as 100 mg/dL or more in a voided specimen or 30 mg/dL in a catheterized specimen. Hyperuricemia was defined as 1 sd or more above the normal mean concentration corrected for gestational age (10) . Transient hypertensive patients also were nulliparous and met the same criteria for hypertension as those described for the preeclampsia group, with resolution of the elevated blood pressure by the 12th postpartum week. However, these women had neither proteinuria nor hyperuricemia (11) . The duration of elevated blood pressure in the two hypertensive groups (6 -10 days) did not differ.
Measurements of blood pressure and BMI
Blood pressures were calculated from the average of at least three blood pressure readings (Korotkov V, seated position) taken before 20 completed weeks gestation and again during the early intrapartum period, before iv fluid or pharmacological (including anesthetic) therapy was administered. BMI, defined as weight (kilograms)/height 2 (meters), was selected as the best practical index of obesity and body composition (12) . The heights and weights of each patient were obtained from the prenatal record.
Plasma collection and determinations
To avoid potential fetal effects of maternal ketosis, venipuncture was performed in nonfasting gravidas. Plasma samples were collected between 0900 -1300 h in 5 mmol/L ethylenediamine tetraacetate approximately 1 week before delivery and frozen at Ϫ70 C. The 36 matched plasma specimens were thawed and analyzed for TxPA, NEFA, and triglyceride concentrations as described below.
TxPA determinations
A slab-gel modification of the electrofocusing assay of Arbogast et al. (6) was developed to quantify TxPA, the pI 5.6 isoform of plasma albumin. Isoelectric focusing (IEF) was carried out in 10% polyacrylamide gels using the Bio-Rad 111 mini-gel system (Richmond, CA). In a series of comparative experiments, this simplified IEF-PAGE assay was shown to correlate accurately with the sucrose gradient electrofocusing assay of Arbogast et al. (6) . Albumin isoforms were stained selectively with 0.1% bromocresol green (6) , and the gels were fixed and scanned. Bromocresol green-positive bands in the IEF-PAGE assays that comigrated with fatty acid free albumin (pI 5.6) were integrated by laser densitometry and referred to as TxPA. Quantification of TxPA bands in the IEF-PAGE assay was linear for both exogenous and endogenous NEFA-free albumin. Endogenous TxPA was examined over a range of 0.2-2.0 L pregnancy plasma and was found to be linear up to 1.2 L plasma. The TxPA bands were normalized to an internal standard included in each experiment.
NEFA and triglyceride determinations
Plasma NEFA were quantified using a microtiter plate modification of the NEFA C diagnostic kit (Wako Pure Chemicals, Richmond, VA). In our laboratory this assay had a sensitivity of 0.02 mmol/L, with interand intraassay coefficients of variation of 12% and 3%, respectively. Plasma triglycerides were quantified in matched patients using a microtiter plate modification of the Sigma triglycerides diagnostic kit. The colorimetric assay had a sensitivity of 1 mg/dL, with inter-and intraassay coefficients of variation of 3% and 1%, respectively.
Lipid extraction from plasma albumin
Albumin was purified from pooled plasma samples by affinity chromatography. Briefly, 1 mL plasma was loaded onto a 1-mL Affi-Blue Sepharose column, and after washing, the retained proteins were eluted by increasing the sodium concentration to 1 mol/L. The fractions containing the eluted proteins were pooled and dialyzed against 20 mmol/L phosphate buffer (pH 7.4). Protein concentrations were determined using the Bradford method (13), and the purity of the samples was assessed by SDS-PAGE (14) , which demonstrated a single band of 68 kDa. Pooled plasma albumin fractions were delipidated according to the chloroform/methanol procedure of Bligh and Dyer (15) . Lipids obtained from the extraction were solubilized in hexanes, evaporated to dryness, and stored under nitrogen at Ϫ20 C before analysis.
GC/MS
A qualitative assessment of the fatty acids extracted from pregnancy plasma albumin was afforded by negative liquid secondary ion mass spectrometry (LSIMS) using an MS50 mass spectrometer (Kratos, Manchester, UK). The spectra generated from each peak allowed definitive identification of the fatty acids bound to plasma albumin. To determine the concentration of fatty acids extracted from plasma albumin, these samples were methylated by the methanolic-HCl method, according to the manufacturer's protocol (Supelco, Bellefonte, PA), and subjected to GC/MS analysis. Methyl fatty acid peaks were normalized using an internal standard (methyl erucic acid, 27:2). The GC/MS was performed on a Hewlett-Packard model 5890 gas chromatograph (Palo Alto, CA) coupled to a VG-70SE mass spectrometer (Micromass, Manchester, UK). The GC was equipped with a 25-m BPX5 column (SGE) with a 1-m film thickness of fused silica. The conditions of elution were as follows: 60 C for 0.5 min with increasing temperature increments of 15 C/min until 100 C was reached, then the temperature was ramped by increments of 20 C/min until a final temperature of 280 C was reached and sustained for 20 min. Total ions were quantified. The GC/MS method was calibrated using test mixtures of 1:1 and 1:2 molar ratios of oleic and palmitic fatty acid standards. The ratio of the integrated surface areas matched the ratio of masses of the fatty acids injected, yielding response factors of ϳ1.
Endothelial cell cultures
HUVE cells were isolated and cultured using a modification of the method of Jaffe et al. (16) as described by us previously (17) . Briefly, endothelial cells were flushed from neonatal umbilical cords after collagenase digestion (1 mg/mL; 15 min at 37 C) and cultured in medium 199 supplemented with 20% FBS and antibiotics. At confluence, the medium was changed to serum-free medium 199 containing 20 mmol/L HEPES (pH 7.4), 500 g/mL BSA, 5 g/mL transferrin, and 1 g/mL insulin. Human VLDL (Sigma; 100 g/mL protein), human fatty-acid free albumin, and increasing concentrations of oleic acid were added to triplicate wells of HUVE cells in 96-well plates (Becton Dickinson, Lincoln Park, NJ). Cell viability was determined using the colorimetric MTT assay (Sigma).
Statistical analyses
Data are presented as the mean Ϯ sd of each study group. ANOVA and Scheffe's post-hoc tests were used to make comparisons among the normal, preeclamptic, and transient hypertensive pregnant patients. Linear regression analyses were used to compare matched results from the IEF-PAGE assay with the sucrose gradient IEF assay and to assess the correlation among clinical biochemistry indicators. For all comparisons, two-tailed tests were accepted as significant when P Ͻ 0.01.
Results
The demographic and clinical data shown in Table 1 demonstrate the successful matching of severely preeclamptic women and their controls with respect to maternal age, parity, and BMI. The mean duration of gestation was significantly shorter in those patients with severe preeclampsia than in the other two groups. The mean (Ϯsd) durations of gestation for each of the three groups were as follows: normal, 39 Ϯ 2 weeks; preeclampsia, 34 Ϯ 4 weeks; and transient hypertension, 40 Ϯ 2 weeks. ANOVA (P Ͻ 0.01) and Scheffe's post-hoc tests indicated that the women with severe preeclampsia had significantly shorter gestations than the other two patient groups (P Ͻ 0.01). Likewise, the neonatal birth weights and placental weights were lowest in the women with severe preeclampsia (P Ͻ 0.01). As expected from the diagnostic definitions, the mean Ϯ sd systolic and diastolic blood pressures were higher in preeclamptic and transient hypertensive women than in the normal controls (P Ͻ 0.01), and proteinuria and serum uric acid levels were highest in the severe preeclampsia group (P Ͻ 0.01). Plasma hemoglobin levels showed subtle differences among the three groups, but these did not reach the assigned level of statistical significance. Figure 1A shows the results of a typical IEF-PAGE analysis, with standards in the left lanes and patient samples on the right. Lane 1 contains 50 g fatty acid-free human albumin and shows a major protein species migrating at pI 5.6 (TxPA). Lane 2 contains 50 g fatty acid-free human albumin preincubated with a 10-fold molar excess of oleic acid, and a shift to the pI 4.8 isoform is observed. Lane 3 contains a mixture of the two previous standards and demonstrates that both isoforms are resolved by IEF-PAGE. At the right, 1-L plasma samples from a normal pregnant woman and a matched severely preeclamptic patient demonstrate the shift to a more acidic albumin phenotype in the latter case. Figure 1B shows the linear relationship, up to 1.2 L plasma, between the detection of TxPA and the volume of plasma subjected to IEF-PAGE. The reproducibility of the IEF-PAGE quantification also was evaluated. The inter-and intraassay coefficients of variation were both 12% in 10 independent determinations of plasma TxPA at a mean concentration of 2.0 g/dL. Direct comparisons of the IEF-PAGE assay with the previously standardized sucrose density gradient IEF assay (6) were performed in 22 independent specimens. A high degree of correlation between the 2 assays (r ϭ 0.56; P Ͻ 0.01) was noted.
The TxPA bands in each of 36 plasma samples were quantified by densitometry and normalized to an internal pI 5.6 albumin standard run in parallel. The results, grouped according to clinical category, are shown as a scattergram in Fig. 2 . The mean Ϯ sd for each of the 3 groups are as follows: normal, 2.30 Ϯ 0.54 g/dL; severe preeclampsia, 1.57 Ϯ 0.47 g/dL; and transient hypertension, 2.75 Ϯ 0.40 g/dL. ANOVA (P Ͻ 0.01) and Scheffe's post-hoc tests indicated that the women with severe preeclampsia had significantly lower TxPA than the other 2 patient groups (P Ͻ 0.01).
Plasma NEFA and triglycerides also were measured in the blood samples. NEFA levels were 0.40 Ϯ 0.15, 1.16 Ϯ 0.30, and 0.62 Ϯ 0.23 mmol/L in the normal, preeclamptic, and transient hypertensive pregnant women, respectively. The distribution of these results is shown as a scattergram in Fig.  3 . Statistical analyses indicated that the plasma NEFA concentrations were significantly different among the groups (by ANOVA, P Ͻ 0.01) and that preeclamptic women had higher levels than the other two patient groups (P Ͻ 0.01). Triglyceride concentrations in normal, preeclamptic, and transient hypertensive pregnant women were 166 Ϯ 56, 246 Ϯ 92, and 224 Ϯ 99 mg/dL, respectively. By ANOVA, these values did not reach a significant level of statistical difference (P ϭ 0.07).
Regression analyses performed independently of the patient groups indicated that plasma TxPA and NEFA concentrations were inversely correlated (r ϭ Ϫ0.53; P Ͻ 0.01). Having confirmed that plasma TxPA levels were decreased in severe preeclampsia and were inversely related to NEFA concentrations, we conducted GC/MS analyses to ascertain which lipids were bound to albumin purified from pregnancy plasma. Because we had observed no statistical differences in TxPA or NEFA between the normal and transient hypertensive groups, the following studies were designed to compare normal pregnant women and severely preeclamptic patients.
Albumin was isolated by Affi-Blue Sepharose affinity chromatography from pooled plasma obtained from the normal and preeclamptic patient groups. Equal amounts of albumin (30 nmol each) were extracted according to the method of Bligh and Dyer (15) . The extracted lipids were solubilized in hexanes and analyzed by mass spectrometry. The moieties detected by negative ion LSIMS arose as deprotonated molecules, (M-H) Ϫ1 . The ions were separated in the mass analyzer based on their mass to charge (m/z) ratios and were detected by an electron multiplier. The mass spectra showed prominent peaks at m/z 255, 279, 281, and 283, which corresponded to palmitic, linoleic, oleic, and stearic acids, respectively (see Fig. 4A ).
We used GC/MS to quantify the fatty acids bound to albumin isolated from normal and preeclamptic patients. In preliminary experiments we showed that the relationship between the amount of a methylated fatty acid standard (methyl erucic acid, 27:2) and the peak area was linear over a concentration range varying from 0.03-0.64 nmol (data not shown). Therefore, we used this methylated compound as an internal standard to determine the relative amounts of fatty acids bound to the albumin samples. Figure 4 , B and C, shows representative chromatograms from normal and preeclampsia plasma pools, respectively. As in the LSIMS analyses, the electron impact spectra of these peaks showed that palmitic, linoleic, oleic, and stearic acids were the predominant fatty acids bound to normal plasma albumin. In the preeclamptic samples (Fig. 4C) , five major peaks were detectable. Based upon their mass determinations, these were identified as the methyl esters of palmitic, linoleic, oleic, and stearic acids. Two isomeric forms of linoleic acid (eluting at 59.5 and 60.5 min) were observed. Based on the recovery of the methyl erucic acid standard, we calculated the total recovery of albumin-bound fatty acids after extraction and GC/MS to be 40%. Integration of the peak areas revealed that 1 nmol plasma albumin contained 0.8 and 2.5 nmol total fatty acids in normal and preeclampsia plasma samples, respectively. These findings are not the result of decreased albumin mass in the severe preeclampsia patients, as the total plasma albumin concentrations did not differ between the 2 patient groups (3.3 Ϯ 0.7 and 3.4 Ϯ 0.9 g/dL in normal pregnancy and severe preeclampsia, respectively; P ϭ 0.89). Only 1 of 12 severe preeclamptics had elevated liver enzymes, and this subject had neither an unusually low TxPA nor total albumin level.
To investigate the possible biological effect of the increased NEFA/albumin ratio observed in plasma from women with severe preeclampsia, we used an in vitro model of human endothelial cell toxicity. HUVE cells grown to confluence in 96-well plates were rinsed and incubated for 24 h in fresh, serum-free medium. To mimic the conditions present in preeclampsia, the cell cultures were exposed to increasing molar ratios of oleic acid/albumin (from 0 -10). The MTT assay was used to assess cell viability. No direct effect of this treatment on HUVE cell viability was observed (Fig. 5) . However, when the cells were incubated with human VLDL (100 g/ mL   FIG. 4 . A, The identities of the fatty acids bound to pregnancy plasma albumin, detected by negative ion LSIMS, were confirmed by their spectra with masses corresponding to palmitic (P), linoleic (L), oleic (O), and stearic (S) acids. B and C, Representative gas chromatograms of fatty acids extracted from albumin of normal (B) and preeclampsia (C) plasma pools are shown. Total ion absorption is plotted on the ordinate, and elution time is shown on the abscissa. In normal plasma, four peaks corresponding to the methyl esters of palmitic (P), linoleic (L), oleic (O), and stearic (S) acids were resolved. In preeclampsia plasma, five major peaks were detectable. Based upon their mass determinations, these also were identified as methyl esters of palmitic (P), oleic (O), and stearic (S) acids. Two isomeric forms of linoleic acid (L 1 and L 2 , eluting at 59.5 and 60.5 min, respectively) were observed. FIG. 5. HUVE cells cultured in serum-free medium were incubated for 24 h with 2.5 g/dL fatty acid-free human albumin and increasing molar concentrations of oleic acid (abscissa). In the absence of human VLDL, there was no effect on HUVE cell viability (open symbols); however, with the further addition of VLDL (100 g/mL protein), a substantial decrease in HUVE cell survival was observed when the oleic acid/albumin ratio exceeded 1.5 (closed symbols). HUVE cell viability was severely impaired when the cells were incubated with VLDL in the absence of albumin (stippled area).
protein) in the absence of human albumin, more than 95% of the cells did not survive. Addition of 2.5 g/dL fatty acid-free human albumin (pI 5.6) prevented the VLDL-induced cytotoxicity. This concentration of albumin was chosen to approximate the mean level of TxPA detected in normal pregnancy plasma (see Fig. 2 ). The protective effect of exogenous human albumin was lost with increasing molar ratios of oleic acid/albumin. The cytotoxicity threshold molar ratio of ϳ1.5 (oleic acid/albumin) observed in vitro (Fig. 5) approximates the ratio observed in vivo in the plasma of women with severe preeclampsia (NEFA/albumin ratio ϭ 2.5).
Discussion
The biochemical findings reported here confirm and extend previous observations by ourselves (6) and others (3, 4, 18, 19) demonstrating that plasma NEFA are increased in women with preeclampsia. In the current study we controlled for race, BMI, and age. Our patients with severe preeclampsia had 2-to 3-fold higher plasma NEFA concentrations than matched normal controls. Interestingly, pregnant women with transient hypertension had plasma NEFA levels significantly lower than preeclamptic patients with similar degrees of hypertension, and the former were indistinguishable from normal controls. A recent report indicates that increased hepatic lipase activity in preeclampsia may contribute to elevated NEFA levels in preeclamptic women (20) . These observations emphasize that the pathophysiology of preeclampsia is more than pregnancy-induced hypertension, as argued by others (21) .
The finding that plasma NEFA levels are inversely proportional to TxPA concentrations is consistent with the hypothesis that fatty acid binding to plasma albumin is responsible for its shift in pI (5, 6) . We directly tested this hypothesis by quantifying the amount of fatty acid bound to plasma albumin in normal and preeclamptic women. The results of our GC/MS analyses indicate that there is quantitatively more NEFA bound to albumin in preeclampsia than in normal pregnancy. The conversion of pI 5.6 albumin to pI 4.8 albumin not only results from the neutralization of basic charges by bound fatty acids, but also reflects a conformational change in the albumin molecule (22) . Albumin with an average of 1.3 mol NEFA bound focuses at pI 5.6, whereas albumin with 2.5-10 mol NEFA focuses at pI 4.8 (23) . This conformational change accounts for the abrupt loss of cytoprotective activity of TxPA when the molar ratio of oleic acid/albumin exceeds 1.5. In severe preeclampsia, elevated NEFA levels appear to saturate the buffering capacity of TxPA.
The 3-fold increase in albumin-bound NEFA is consistent with the 3-fold increase in total detectable NEFA circulating in these women. The NEFA/albumin ratios of 2.5 and 0.8 that we have calculated directly in severely preeclamptic and normal pregnant women are very similar to the 1.6 and 0.9 ratios estimated by Endresen and colleagues (4) in preeclamptic and normal pregnant women, respectively. Although preeclampsia is a relatively proteinuric state, the high NEFA/albumin ratio in severe preeclamptics is not simply a consequence of decreased total plasma albumin in these women. Indeed, their total circulating albumin concentrations were not different from those in normal pregnant women. This observation is similar to our findings in mildly preeclamptic women and their matched controls (6) and probably reflects the sampling of these patients before florid signs of the syndrome were manifested.
It is not surprising that women with severe preeclampsia were delivered after a shorter mean gestation than the two control groups. Even at the current time, expedient delivery is the most effective clinical management of severe preeclampsia (21) . The shorter pregnancy duration in the preeclampsia group is not a confounder for the TxPA and lipid measurements. In fact, TxPA levels tend to fall during gestation, whereas NEFA levels increase during the course of gestation (6) . Thus, the effects of pregnancy duration would mitigate against, rather than accentuate, differences in these parameters among the three groups. The hemoglobin results indicate that differences among the patient groups were not due to differences in hemoconcentration of the preeclamptic women.
Our in vitro studies suggest that the NEFA/albumin ratios observed in severely preeclamptic women may approach levels at which human endothelial cell viability is compromised. Previous studies by ourselves (24, 25) and others (18) failed to detect evidence of endothelial cell death after exposure to low (Յ30%) concentrations of serum from preeclamptic women. However, when cultured endothelial cells were further challenged by the addition of VLDL particles, the presence of TxPA correlated with the prevention of cytotoxicity in HUVE cells. Similar effects were observed previously in porcine aortic endothelial cells (26) . The biological characteristics of toxic principles associated with VLDL remain unknown (27) . Endotoxin has been suggested as a possible candidate, but this can be difficult to detect biochemically in lipoproteins (28) .
In summary, our findings support the concept that endothelial cell dysfunction in preeclampsia may be a manifestation of lipid-induced injury to those cells. Patients with severe preeclampsia have 2-to 3-fold higher concentrations of NEFA than those with transient hypertension or normal pregnancies. The acidic shift in the pI of plasma albumin in preeclamptic patients appears to be the result of increased NEFA binding to albumin molecules. We postulate that elevated concentrations of NEFA either directly, by alteration of albumin function, or via intracellular incorporation into triglyceride (4, 29) perturb maternal endothelial cell function, leading to systemic manifestations of preeclampsia (30) . Increased endothelial cell uptake of NEFA, particularly linoleic and arachidonic acids, may lead to abnormalities of PG metabolism associated with clinical preeclampsia (31) and in vitro models of this disorder (32, 33) . Future therapeutic strategies to prevent excessive cellular NEFA uptake may reduce the development or progression of preeclampsia.
